Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Alembic Ltd.

  • NSE: ALEMBICLTD

  • BSE: 506235

  • Q
  • V
  • T
  • Expensive Star
70.90/100

Quality Score

High Financial Strength
20.67/100

Valuation Score

Expensive Valuation
77.26/100

Technical Score

Technically Bullish
Broker Average Rating

0.00

Broker Average Rating

MFI

76.96

MFI Overbought

50Day SMA Rs

90.66 Rs

Price above SMA 90.66

Quality score

70.90

High Financial Strength

30Day SMA Rs

95.16 Rs

Price above SMA 95.16

Broker Covering stock

0.00

0 Broker Covering stock

Broker 6M Target upgrade

0.00

0 Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

0 Broker 6M Target downgrade

Momentum score

77.26

Technically Bullish

Price to Book Ratio

1.91

Below industry Median

Broker Reports in 1Yr

0.00

0 Broker Reports in 1Yr

TTM PE Ratio

28.92

Above industry Median

Broker 6M Reco upgrade

0.00

0 Broker 6M Reco upgrade

RSI

55.56

RSI is mid-range

Net Profit Qtr Cr

2.11 Cr

Above industry Median

AVG Broker Target

-100.00 %

No targets last year

Operating Revenues Qtr Cr

13.39 Cr

Below industry Median

MACD

7.25

MACD above Signal and Center

Valuation score

20.67

Expensive Valuation

MACD Signal Line

6.89

MACD above Signal and Center

FII holding holding %

1.86 %

FII holding increased by 0.06%.

Promoter holding holding %

69.57 %

Promoter holding increased by 1.95%.

MF holding holding %

3.89 %

MF holding decreased by 1.95%.

Broker 6M Reco downgrade

0.00

0 Broker 6M Reco downgrade

100Day SMA Rs

77.63 Rs

Price above SMA 77.63

Institutions holding holding %

5.88 %

Institutions holding decreased by 1.86%.

AVG Broker Target

0.00 Rs

No targets last year

200Day SMA Rs

63.98 Rs

Price above SMA 63.98

NSE ALEMBICLTD
0.00
  • 0.00 Close
  • 0.00 Open
  • 0.00 Volume
Today Low/High
Low 0.00
High 0.00
52 Week Low/High
0.00
0.00

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Alembic Ltd. 105.5 28.92 2709.05 0.56 2.1 0 13.38 -48.57 1.91
Sun Pharmaceutical Industries Ltd. 508.85 477.65 122088.38 0.78 -2429.81 0 7585.25 -9.43 2.48
Divi's Laboratories Ltd. 3236.6 53.82 85915.54 0.49 492.06 0 1730.47 48.8 11.75
Dr. Reddy's Laboratories Ltd. 5167.95 45.28 85891.32 0.48 586.9 0 4426.5 14.72 5.51
Cipla Ltd. 777.65 38.05 62698.03 0.51 571.42 0 4346.16 8.95 3.9
Lupin Ltd. 1039.75 -100.82 47111.07 0.57 108.14 0 3527.86 -20.16 3.74
Aurobindo Pharma Ltd. 799.1 15.57 46819.26 0.53 792.68 0 5924.78 8.81 2.78
Torrent Pharmaceuticals Ltd. 2726.65 40.83 46145.82 1.17 321 0 2056 1.68 9.56